Tetrachloro-p-benzoquinone induces hepatic oxidative damage and inflammatory response, but not apoptosis in mouse: the prevention of curcumin. 2014

Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, People's Republic of China.

This study investigated the protective effects of curcumin on tetrachloro-p-benzoquinone (TCBQ)-induced hepatotoxicity in mice. TCBQ-treatment causes significant liver injury (the elevation of serum AST and ALT activities, histopathological changes in liver section including centrilobular necrosis and inflammatory cells), oxidative stress (the elevation of TBAR level and the inhibition of SOD and catalase activities) and inflammation (up-regulation of iNOS, COX-2, IL-1β, IL-6, TNF-α and NF-κB). However, these changes were alleviated upon pretreatment with curcumin. Interestingly, TCBQ has no effect on caspase family genes or B-cell lymphoma 2 (Bcl-2)/Bcl-2 associated X (Bax) protein expressions, which implied that TCBQ-induced hepatotoxicity is independent of apoptosis. Moreover, curcumin was shown to induce phase II detoxifying/antioxidant enzymes HO-1 and NQO1 through the activation of nuclear factor erythroid-derived 2-like 2 (Nrf2). In summary, the protective mechanisms of curcumin against TCBQ-induced hepatoxicity may be related to the attenuation of oxidative stress, along with the inhibition of inflammatory response via the activation of Nrf2 signaling.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric
D006843 Hydrocarbons, Chlorinated Hydrocarbon compounds with one or more of the hydrogens replaced by CHLORINE. Chlorinated Hydrocarbon,Chlorinated Hydrocarbons,Organochlorine Compound,Chlorine Compounds, Organic,Organochlorine Compounds,Compound, Organochlorine,Compounds, Organic Chlorine,Compounds, Organochlorine,Hydrocarbon, Chlorinated,Organic Chlorine Compounds
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D016227 Benzoquinones Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. 1,2-Benzoquinones,1,4-Benzoquinones,Benzodiones,2,5-Cyclohexadiene-1,4-Diones,o-Benzoquinones,p-Benzoquinones

Related Publications

Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
January 2017, Journal of environmental sciences (China),
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
October 2006, Journal of enzyme inhibition and medicinal chemistry,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
November 1995, Environmental science & technology,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
November 2018, European review for medical and pharmacological sciences,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
January 2017, Journal of environmental sciences (China),
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
February 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
April 2001, Carcinogenesis,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
January 1949, Helvetica chimica acta,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
January 2022, Frontiers in pharmacology,
Demei Xu, and Lihua Hu, and Chuanyang Su, and Xiaomin Xia, and Pu Zhang, and Juanli Fu, and Wenchao Wang, and Duo Xu, and Hong Du, and Qiuling Hu, and Erqun Song, and Yang Song
May 2022, International immunopharmacology,
Copied contents to your clipboard!